Amoneta Diagnostics (a Firalis affiliate) raises funds via Crowdfunding

You can have a part of Amoneta Diagnostics via Crowdfunding operation open now !

Click here to know more.

Amoneta develops a biomarker based non-invasive, simple and realiable blood test for early diagnosis of Alzheimer supported by several EU funding.

As agreed by the majority of KOLs; "an efficient and simple diagnosis of Alzheimer's Disease based on innovative biomarkers is essential to come up with better treatments".

Comments are closed.